脂肪营养不良综合征临床实践指南——日本内分泌学会（JES）的重要临床疾病 - Suppr

Practice guideline for lipodystrophy syndromes-clinically important diseases of the Japan Endocrine Society (JES).

作者信息

Tanaka Tomohiro, Kusakabe Toru, Ebihara Ken, Aizawa-Abe Megumi, Aotani Daisuke, Yorifuji Tohru, Satoh Mari, Ogawa Yoshihiro, Nakao Kazuwa

机构信息

Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.

Department of Gastroenterology and Metabolism, Graduate School of Medical Sciences and Medical School, Nagoya City University, Nagoya 467-8601, Japan.

出版信息

Endocr J. 2021 Sep 28;68(9):1027-1042. doi: 10.1507/endocrj.EJ21-0110. Epub 2021 Aug 7.

DOI:10.1507/endocrj.EJ21-0110

PMID:34373417

Abstract

摘要

相似文献

Practice guideline for lipodystrophy syndromes-clinically important diseases of the Japan Endocrine Society (JES).

Endocr J. 2021 Sep 28;68(9):1027-1042. doi: 10.1507/endocrj.EJ21-0110. Epub 2021 Aug 7.

[Uncommon lipodystrophic syndromes].

Med Clin (Barc). 2015 Jan 20;144(2):80-7. doi: 10.1016/j.medcli.2014.02.024. Epub 2014 Apr 29.

Leptin replacement therapy in the management of lipodystrophy syndromes.

Ann Endocrinol (Paris). 2024 Jun;85(3):201-204. doi: 10.1016/j.ando.2024.05.022. Epub 2024 Jun 12.

Diagnosis and treatment of lipodystrophy: a step-by-step approach.

J Endocrinol Invest. 2019 Jan;42(1):61-73. doi: 10.1007/s40618-018-0887-z. Epub 2018 Apr 27.

Lipodystrophic syndromes: From diagnosis to treatment.

Ann Endocrinol (Paris). 2020 Feb;81(1):51-60. doi: 10.1016/j.ando.2019.10.003. Epub 2019 Dec 16.

How to diagnose a lipodystrophy syndrome.

Ann Endocrinol (Paris). 2012 Jun;73(3):170-89. doi: 10.1016/j.ando.2012.04.010. Epub 2012 Jun 28.

Partial lipodystrophy: Clinical presentation and treatment.

Ann Endocrinol (Paris). 2024 Jun;85(3):197-200. doi: 10.1016/j.ando.2024.05.015. Epub 2024 Jun 12.

Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement.

Metabolism. 2019 Jul;96:66-82. doi: 10.1016/j.metabol.2019.05.001. Epub 2019 May 6.

Lipodystrophy syndromes.

Dermatol Clin. 2008 Oct;26(4):569-78, ix. doi: 10.1016/j.det.2008.05.004.

Generalized weight loss in a child. Generalized lipodystrophy.

Arch Dermatol. 1988 Apr;124(4):573, 576. doi: 10.1001/archderm.124.4.573.

引用本文的文献

Severe obesity with hypo-leptinemia.

Endocr J. 2025 Jul 1;72(7):801-811. doi: 10.1507/endocrj.EJ24-0568. Epub 2025 Mar 22.

Celebrating the 100 anniversary of the Japan Endocrine Society: reflecting on my 50 years of hormone research.

Endocr J. 2025;72(1):1-21. doi: 10.1507/endocrj.EJ20241105.

A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02).

J Diabetes Investig. 2024 Sep;15(9):1211-1219. doi: 10.1111/jdi.14226. Epub 2024 May 4.

Influence of diet and body weight in treatment-resistant acquired partial lipodystrophy after hematopoietic stem cell transplantation and its potential for metabolic improvement.

Diabetol Int. 2023 Dec 11;15(2):290-296. doi: 10.1007/s13340-023-00674-6. eCollection 2024 Apr.

A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01).

Diabetes Ther. 2024 Feb;15(2):533-545. doi: 10.1007/s13300-023-01526-x. Epub 2024 Jan 13.

A Qualitative Research Study of Experiences and Perceptions of People Living with Insulin Resistance Syndrome or Lipoatrophic Diabetes in Japan.

Diabetes Ther. 2023 Aug;14(8):1345-1356. doi: 10.1007/s13300-023-01412-6. Epub 2023 Jun 8.

Treatment Options for Lipodystrophy in Children.

Front Endocrinol (Lausanne). 2022 May 4;13:879979. doi: 10.3389/fendo.2022.879979. eCollection 2022.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Practice guideline for lipodystrophy syndromes-clinically important diseases of the Japan Endocrine Society (JES).

Endocr J. 2021 Sep 28;68(9):1027-1042. doi: 10.1507/endocrj.EJ21-0110. Epub 2021 Aug 7.

[Uncommon lipodystrophic syndromes].

Med Clin (Barc). 2015 Jan 20;144(2):80-7. doi: 10.1016/j.medcli.2014.02.024. Epub 2014 Apr 29.

Leptin replacement therapy in the management of lipodystrophy syndromes.

Ann Endocrinol (Paris). 2024 Jun;85(3):201-204. doi: 10.1016/j.ando.2024.05.022. Epub 2024 Jun 12.

Diagnosis and treatment of lipodystrophy: a step-by-step approach.

J Endocrinol Invest. 2019 Jan;42(1):61-73. doi: 10.1007/s40618-018-0887-z. Epub 2018 Apr 27.

Lipodystrophic syndromes: From diagnosis to treatment.

Ann Endocrinol (Paris). 2020 Feb;81(1):51-60. doi: 10.1016/j.ando.2019.10.003. Epub 2019 Dec 16.

How to diagnose a lipodystrophy syndrome.

Ann Endocrinol (Paris). 2012 Jun;73(3):170-89. doi: 10.1016/j.ando.2012.04.010. Epub 2012 Jun 28.

Partial lipodystrophy: Clinical presentation and treatment.

Ann Endocrinol (Paris). 2024 Jun;85(3):197-200. doi: 10.1016/j.ando.2024.05.015. Epub 2024 Jun 12.

Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement.

Metabolism. 2019 Jul;96:66-82. doi: 10.1016/j.metabol.2019.05.001. Epub 2019 May 6.

Lipodystrophy syndromes.

Dermatol Clin. 2008 Oct;26(4):569-78, ix. doi: 10.1016/j.det.2008.05.004.

Generalized weight loss in a child. Generalized lipodystrophy.

Arch Dermatol. 1988 Apr;124(4):573, 576. doi: 10.1001/archderm.124.4.573.

引用本文的文献

Severe obesity with hypo-leptinemia.

Endocr J. 2025 Jul 1;72(7):801-811. doi: 10.1507/endocrj.EJ24-0568. Epub 2025 Mar 22.

Celebrating the 100 anniversary of the Japan Endocrine Society: reflecting on my 50 years of hormone research.

Endocr J. 2025;72(1):1-21. doi: 10.1507/endocrj.EJ20241105.

A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02).

J Diabetes Investig. 2024 Sep;15(9):1211-1219. doi: 10.1111/jdi.14226. Epub 2024 May 4.

Influence of diet and body weight in treatment-resistant acquired partial lipodystrophy after hematopoietic stem cell transplantation and its potential for metabolic improvement.

Diabetol Int. 2023 Dec 11;15(2):290-296. doi: 10.1007/s13340-023-00674-6. eCollection 2024 Apr.

A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01).

Diabetes Ther. 2024 Feb;15(2):533-545. doi: 10.1007/s13300-023-01526-x. Epub 2024 Jan 13.

A Qualitative Research Study of Experiences and Perceptions of People Living with Insulin Resistance Syndrome or Lipoatrophic Diabetes in Japan.

Diabetes Ther. 2023 Aug;14(8):1345-1356. doi: 10.1007/s13300-023-01412-6. Epub 2023 Jun 8.

Treatment Options for Lipodystrophy in Children.

Front Endocrinol (Lausanne). 2022 May 4;13:879979. doi: 10.3389/fendo.2022.879979. eCollection 2022.

Practice guideline for lipodystrophy syndromes-clinically important diseases of the Japan Endocrine Society (JES).

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献